Alkem Laboratories Limited

Alkem Laboratories Limited

Alkem Laboratories has completed the acquisition of at least 51% of Occlutech Holding AG, a Swiss company, through its subsidiary Alkem Medtech Private Limited.

Alkem Laboratories Limited

Alkem Laboratories Limited has informed the Exchange regarding Notice of Court Convened General Meeting to be held on August 17, 2026, to consider and approve the Scheme of Amalgamation between Alkem Laboratories Limited and Adroit Biomed Limited.

Alkem Laboratories Limited

Alkem Laboratories Limited has informed the Exchange about a Copy of Newspaper Publication regarding the 52nd Annual General Meeting to be held through video conferencing (VC)/other audio visual means (OAVM) on 27th August, 2026.

Alkem Laboratories Limited

Alkem Laboratories Limited has received favourable Orders-in-Appeal from the Commissioner of Income Tax, Appeal – 47, Mumbai, deleting disallowances made under section 80-IE of the Income-tax Act, 1961, involving a tax amount of Rs. 660.77 Crores. The orders were received on 30th June, 2026.